Nephrocare Health Services
Listed
Listed
IPO Timeline
Issue open date
10 Dec 2025Issue close date
12 Dec 2025UPI mandate deadline
12 Dec 2025Allotment finalization
15 Dec 2025Refund initiation
16 Dec 2025Share credit
16 Dec 2025Listing date
17 Dec 2025Mandate end date
27 Dec 2025Lock-in end date for anchor investors (50%)
14 Jan 2026Lock-in end date for anchor investors (remaining)
15 Mar 2026Grey Market Premium Trend
₹40
Current GMP
₹500
Est. Listing Price
8.7%
Est. Listing Gain
₹438 - ₹460
Price Band
GMP History
| Date | GMP (₹) | Est. Listing Price (₹) | Est. Listing Gain |
|---|---|---|---|
| 16 Dec | ₹40 | ₹500 | 8.70% |
| 15 Dec | ₹37 | ₹497 | 8.04% |
| 14 Dec | ₹37 | ₹497 | 8.04% |
| 13 Dec | ₹35 | ₹495 | 7.50% |
| 12 Dec | ₹33 | ₹493 | 7.17% |
| 11 Dec | ₹33 | ₹493 | 7.17% |
| 10 Dec | ₹12 | ₹472 | 2.50% |
| 9 Dec | ₹20 | ₹480 | 4.35% |
| 8 Dec | ₹0 | ₹460 | 0.00% |
| 7 Dec | ₹0 | ₹460 | 0.00% |
| 6 Dec | ₹0 | ₹460 | 0.00% |
| 5 Dec | ₹0 | ₹460 | 0.00% |
| 4 Dec | ₹0 | ₹460 | 0.00% |
| 3 Dec | ₹0 | ₹460 | 0.00% |
| 2 Dec | ₹0 | ₹460 | 0.00% |
Key Dates
Open
10 Dec 2025Close
12 Dec 2025Listing
17 Dec 2025Quick Stats
Issue Size:871cr
Lot Size:32 shares
About the Company
Nephrocare Health Services (operating under the NephroPlus brand) is a leading provider of dialysis services in India, offering haemodialysis, home haemodialysis, hemodiafiltration, holiday dialysis, dialysis on call, and dialysis on wheels. Founded in 2009 and headquartered in Hyderabad, it operates a network of 447 clinics across 269 cities in 21 states and 4 Union Territories, serving over 33,000 patients annually. The company also has an international presence in the Philippines, Uzbekistan, Nepal, and the Kingdom of Saudi Arabia.
Strengths
- Asia’s largest dialysis provider by treatment volumes.
- 447 centres ensuring broad national geographic reach.
- Innovative models like holiday and mobile dialysis.
- Strong patient base of over 33,000 annually.
- Experienced management backed by private equity funding.
Risks
- Capital-intensive model requiring continuous funding support.
- Quality control challenges across a large clinic network.
- Dependent on kidney disease prevalence and policy support.
- Increasing competition from hospitals and local players.
- High operating costs may pressure profitability margins.
Nephrocare Health Services IPO – Frequently Asked Questions
- The price band for the Nephrocare Health Services IPO is set at ₹438 to ₹460 per share.
- The Nephrocare Health Services IPO opens on December 10, 2025 and closes on December 12, 2025.
- The tentative listing date for the Nephrocare Health Services IPO is December 17, 2025.
- You can apply for the Nephrocare Health Services IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Nephrocare Health Services, enter lot quantity and UPI ID, then approve the mandate.
- The lot size for the Nephrocare Health Services IPO is 32 shares. Investors must apply for at least one lot (i.e., 32 shares).